E Therapeutics (ETX)

 

ETX Share PerformanceMore

52 week high13.25 22/06/17
52 week low6.00 01/06/17
52 week change 1.25 (13.51%)
4 week volume3,256,323 27/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

e-therapeutics schedules interims

e-therapeutics will announce its results for the six months ended 31 July on 26 September. At 9:47am: (LON:ETX) eTherapeu...

Notice of Results

Notification of the date financial results will be published

Director Deals - e-Therapeutics PLC (ETX)

Iain Ross, Chairman, bought 250,000 shares in the company on the 22nd August 2017 at a price of 10.60p. The Director now...

Director Deals - e-Therapeutics PLC (ETX)

Iain Ross, Chairman, bought 250,000 shares in the company on the 22nd August 2017 at a price of 10.60p. The Director now...

Director/PDMR Shareholding

Edison issues update on e-Therapeutics

Edison has issued an update on e-Therapeutics following the business and strategic review undertaken by new chief execut...

Edison issues update on e-Therapeutics (ETX)

e-Therapeutics completes 'root and branch' review

e-Therapeutics has completed a 'root and branch' strategic review which, it said, had confirmed the novelty, utility and pro...

Fundamental DataMore

EPS-4.91
Dividend yield0 %

Equity Research (ETX)

edison investment research
e-Therapeutics plc
27/07/2017
New CEO Dr Ray Barlow, who joined e-Therapeutics (ETX) in April, has undertaken a business and strategic review, assisted by an independent industry-wide expert panel. The portfolio has been...
edison investment research
e-Therapeutics plc
05/05/2017
e-Therapeutics offers public market investors a unique opportunity to gain exposure to a proprietary, cutting-edge in silico drug discovery platform that has already attracted significant investment...
edison investment research
e-Therapeutics plc
16/01/2017
e-Therapeutics (ETX) has appointed a new CEO, Dr Raymond Barlow, who will join the company by 1 May 2017. He brings significant R&D and business development experience, which will be invaluable...

Latest discussion posts More

  • Q1 2017 blog update - ETX

    Q1 2017 blog weekly ETX chart update - notes under each chart: http://bonker99.com/Blogs
    10-Feb-2017
    Bonker
  • ETX chart

    http://bonker99.com/charts
    6-Feb-2017
    Bonker
  • Results

    RNS available at company's website. although seems to be missing in III ...
    22-Mar-2016
    nk1999

Users' HoldingsMore

Users who hold E Therapeutics also hold..
LLOYDS GRP.28%
ROCKHOPPER28%
RENEURON24%
RANGE RES.24%
VODAFONE GRP.20%

Codes & Symbols

ISINGB00B2823H99
SymbolsETX, LSE:ETX, ETX.L, ETX:LN, LON:ETX, XLON:ETX